Teleflex to Showcase the MANTA™ Vascular Closure Device from the Recently Acquired Essential Medical, Inc. at the Annual Me...
January 18 2019 - 6:45AM
Business Wire
Teleflex Incorporated (NYSE: TFX), a leading global provider of
medical technologies with solutions in the fields of vascular and
interventional access, surgical and cardiac care, will showcase the
MANTA™ Vascular Closure Device as well as its portfolio for
peripheral interventions at the Annual Meeting of the Leipzig
Interventional Course (LINC) 2019, in Leipzig, Germany.
With the acquisition of Essential Medical, Inc., Teleflex now
offers the CE Marked MANTA™ Vascular Closure Device specifically
designed for closure of large bore arteriotomies following
procedures utilizing devices or sheaths ranging in size from 10F to
18F (with maximum outer diameters up to 25F). In its CE Mark study,
the MANTA™ Device demonstrated rapid and reliable hemostasis with
its resorbable collagen-based technology and complication rates
that were similar to surgical and suture-based closure
methods.1
Clinicians worldwide rely on the quality and proven clinical
utility of our peripheral intervention portfolio with products such
as Turnpike® Catheters, Supercross® Microcatheters, the Pronto®
Extraction Catheter, Micro Elite™ and Expro Elite™ Snares and the
Hunter™ Biopsy Sealing Device. The MANTA™ Vascular Closure Device
is not commercially available in the United States.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed
to improve the health and quality of people’s lives. We apply
purpose driven innovation - a relentless pursuit of identifying
unmet clinical needs - to benefit patients and healthcare
providers. Our portfolio is diverse, with solutions in the fields
of vascular and interventional access, surgical, anesthesia,
cardiac care, urology, emergency medicine and respiratory care.
Teleflex employees worldwide are united in the understanding that
what we do every day makes a difference. For more information,
please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®,
Pilling®, Rüsch®, UroLift® and Weck® – trusted brands united by a
common sense of purpose.
Forward-Looking Statements
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking
statements. Any forward-looking statements contained herein are
based on our management's current beliefs and expectations, but are
subject to a number of risks, uncertainties and changes in
circumstances, which may cause actual results or company actions to
differ materially from what is expressed or implied by these
statements. These risks and uncertainties are identified and
described in more detail in our filings with the Securities and
Exchange Commission, including our Annual Report on Form 10-K.
References:
1. Van Mieghem NM, Latib A, van der Heyden J, van Gils L, et al.
Percutaneous Plug-Based Arteriotomy Closure Device for Large-Bore
Access: A Multicenter Prospective Study. JACC: Cardiovasc
Intervent. 2017;10(6):613-619.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190118005002/en/
Jake ElguiczeTreasurer and Vice President, Investor
Relations610-948-2836
Emmet DaltonDirector of Marketing Communications InternationalM:
+353 87 333 3262E: emmet.dalton@teleflex.com
Teleflex (NYSE:TFX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Teleflex (NYSE:TFX)
Historical Stock Chart
From Apr 2023 to Apr 2024